Alzheimer’s Treatment Center

Alzheimer's Treatment Center is a specialized clinical research facility and medical practice focused on the diagnosis and treatment of Alzheimer's disease and related cognitive disorders. Based in Albany, New York, the center operates as a high-volume clinical trial site, partnering with major pharmaceutical and biotechnology companies to execute Phase 1 through Phase 4 studies. The center provides patients with access to emerging therapies, including monoclonal antibodies and small molecule inhibitors, while offering comprehensive neurological evaluations. Led by Medical Director Dr. Richard Holub, the organization is a key contributor to the global clinical development landscape for neurodegenerative diseases. The facility is recognized for its recruitment efficiency and high-quality data in pivotal trials for now-approved Alzheimer's treatments.